Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) - Global Forecast to 2030

icon1
USD 13.02
MARKET SIZE, 2030
icon2
CAGR 7.4%
(2025-2030)
icon3
321
REPORT PAGES
icon4
374
MARKET TABLES

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global blood collection devices market is estimated at USD 9.13 billion in 2025 and is projected to reach USD 13.02 billion by 2030, growing at a CAGR of 7.4% during the forecast period. The market is strongly driven by the rising prevalence of infectious diseases, chronic and lifestyle-related conditions, and the increasing number of hospitals and surgical centers worldwide. The growing number of accidents and trauma cases has further increased the need for rapid and reliable blood collection for diagnostics and emergency care. At the same time, the emergence of liquid biopsy tests, which rely on blood samples for early disease detection and monitoring, is driving the demand for advanced collection devices that ensure sample integrity and accuracy. Additionally, growing awareness and the demand for blood donations and blood components are contributing to the expansion of the market, particularly in emerging regions. Collectively, these factors are increasing adoption, improving patient care and diagnostics, and strengthening the overall growth of the global blood collection devices market.

KEY TAKEAWAYS

  • BY PRODUCT
    Based on products, the blood collection devices market is segmented into blood collection tubes, needles & syringes, blood bags, blood collection systems/monitors, and lancets. Among these, blood collection tubes dominate the market, driven by their widespread use in diagnostic testing, routine health check-ups, and blood banking procedures. These tubes enable multiple samples to be collected from a single patient for various tests, ensuring accuracy, convenience, and efficiency in clinical workflows. The growing prevalence of chronic and infectious diseases, coupled with the increasing demand for reliable diagnostic results, further reinforces the strong demand for blood collection tubes. While other products such as needles, syringes, and blood bags play a vital role in overall blood collection processes, tubes remain the largest contributor to market revenue due to their consistent and recurring use across healthcare settings.
  • BY METHOD
    Based on methods, the blood collection devices market is divided into manual and automated blood collection methods. Manual blood collection continues to be widely used across hospitals, clinics, and blood banks due to its simplicity, cost-effectiveness, and adaptability to various clinical settings. It allows healthcare professionals to collect samples with minimal equipment requirements, making it suitable for both routine and emergency procedures. Manual methods remain essential in regions with limited access to advanced technologies, where they support large-scale diagnostic and therapeutic applications efficiently and reliably.
  • BY APPLICATION
    Based on applications, the blood collection devices market is categorized into diagnostic and therapeutic applications. Diagnostic applications account for a major share of usage, as blood testing remains essential for disease detection, health monitoring, and preventive screening. These applications support the identification of infections, chronic diseases, and other medical conditions through accurate and timely blood analysis. Therapeutic applications primarily involve transfusions and related procedures but represent a comparatively smaller portion of overall use. The growing emphasis on early diagnosis and regular health check-ups continues to drive the demand for blood collection devices in diagnostic settings.
  • BY END USER
    Based on end users, the blood collection devices market is categorized into hospitals, ambulatory surgical centers (ASCs), and nursing homes; diagnostic and pathology laboratories; blood banks; and other end users. Hospitals, ASCs, and nursing homes account for a substantial share of the market due to the high number of patient admissions, surgical procedures, and routine diagnostic tests conducted in these facilities. Diagnostic and pathology laboratories also represent a major end-user segment, as blood testing forms the foundation of disease detection, monitoring, and preventive healthcare. Blood banks rely on these devices for efficient collection, processing, and storage of blood and its components. The continuous expansion of healthcare infrastructure and increasing demand for accurate diagnostic testing are expected to further drive the adoption of blood collection devices across all end-user segments.
  • BY REGION
    The blood collection devices market spans North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates the market, supported by a well-established healthcare infrastructure, high diagnostic testing rates, and the strong presence of leading manufacturers. The Asia Pacific region is projected to record the fastest growth due to expanding healthcare access, growing awareness of preventive diagnostics, and increasing demand for advanced blood collection systems across hospitals and diagnostic laboratories.
  • COMPETITIVE LANDSCAPE
    Major players in the blood collection devices market have adopted a mix of organic and inorganic growth strategies, including partnerships, collaborations, and investments to expand their product portfolios and global reach. The top five players in the market include Fresenius Kabi AG; Becton, Dickinson and Company; Terumo BCT, Inc.; Greiner Bio-One; and Cardinal Health. These companies focus on introducing advanced blood collection solutions, enhancing manufacturing capabilities, and strengthening distribution networks to cater to the growing global demand for safe and efficient blood collection.

The blood collection devices market is set to experience steady growth in the coming years, driven by the rising prevalence of infectious, chronic, and lifestyle-related diseases, along with an increasing number of hospitals and surgical centers worldwide. The growing incidence of accidents and trauma cases is further boosting the demand for rapid, safe, and efficient blood collection solutions to support emergency care and diagnostics. Additionally, the emergence of liquid biopsy tests, which utilize blood samples for early detection and monitoring of diseases such as cancer, is creating new growth opportunities for advanced blood collection technologies. Expanding awareness and demand for blood donations and blood components are also contributing to market expansion, particularly in developing regions. Moreover, ongoing improvements in healthcare infrastructure and the introduction of automated and safety-engineered collection systems are enhancing the reliability, efficiency, and accessibility of blood collection across diverse clinical settings.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The blood collection devices market is witnessing notable transformation, driven by the rising prevalence of infectious, chronic, and lifestyle diseases, coupled with growing awareness of preventive healthcare and regular testing. Hospitals, diagnostic laboratories, ambulatory surgical centers, and nursing homes represent the primary end users of blood collection devices. Key trends such as the increasing demand for safe and efficient collection systems, adoption of automated and closed blood collection technologies, and advancements in liquid biopsy and plasma separation techniques are reshaping clinical workflows and collection practices. These developments directly influence the procurement of consumables, instruments, and accessories, thereby strengthening the growth outlook and competitive positioning of blood collection device manufacturers.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising prevalence of infectious diseases and chronic & lifestyle diseases
  • Increasing number of hospitals and surgical centers
RESTRAINTS
Impact
Level
  • Rising costs of automated blood collection devices
OPPORTUNITIES
Impact
Level
  • Increasing demand for apheresis
  • Lucrative opportunities in emerging economies
CHALLENGES
Impact
Level
  • Complex storage and shipping
  • Lack of skilled professionals

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising prevalence of infectious diseases and chronic & lifestyle diseases

The growing incidence of infectious diseases, along with the increasing burden of chronic and lifestyle-related conditions such as diabetes, cardiovascular disorders, and cancer, is a major driver for the blood collection devices market. Regular blood testing is essential for disease diagnosis, monitoring, and management, leading to heightened demand for efficient and accurate blood collection systems. Moreover, the global emphasis on preventive healthcare and early disease detection is encouraging routine health screenings, further supporting the widespread adoption of advanced blood collection devices in hospitals, diagnostic laboratories, and other healthcare settings.

Restraint: Rising costs of automated blood collection devices

The high cost associated with automated and advanced blood collection systems poses a significant restraint to market expansion, particularly in low- and middle-income countries. Automated devices offer advantages such as improved safety, reduced contamination risk, and faster sample processing, but their elevated price limits adoption among smaller healthcare facilities and diagnostic centers with budget constraints. Additionally, the need for specialized infrastructure and maintenance further increases operational expenses, which may hinder widespread implementation in cost-sensitive markets.

Opportunity: Advancements in blood collection

Technological innovations in blood collection, including the development of minimally invasive and closed-system devices, present significant growth opportunities for the market. The emergence of vacuum-based, microcollection, and laser-assisted devices enhances collection efficiency, patient comfort, and sample quality. Furthermore, the integration of automation, digital monitoring, and connectivity solutions supports error reduction and streamlined laboratory operations. These advancements are driving the transition toward safer, faster, and more patient-friendly blood collection methods, expanding adoption across both hospital and point-of-care settings.

Challenge: Lack of skilled professionals

A shortage of skilled healthcare professionals trained in proper blood collection techniques poses a major challenge for the market. Inadequate training can lead to sample contamination, hemolysis, or patient discomfort, compromising diagnostic accuracy and efficiency. This challenge is particularly evident in rural and resource-limited settings where access to trained phlebotomists and laboratory technicians is limited. Addressing this gap through targeted training programs, certification initiatives, and automated solutions will be crucial to ensuring consistent, high-quality sample collection and sustaining market growth.

Blood Collection Devices Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides blood collection and processing solutions for transfusion and therapeutic applications, including collection bags, automated devices, and blood component separators. Enables efficient and sterile blood collection, enhances component quality, reduces wastage, supports safe transfusion practices, and improves donor and patient safety.
Offers a wide range of blood collection systems, including vacuum-based tubes, needles, and safety-engineered devices used across hospitals and diagnostic laboratories. The company’s Vacutainer system is a global standard for routine and specialized blood testing. Ensures accurate and contamination-free sample collection, enhances patient and operator safety, supports high-throughput processing, reduces manual errors, and complies with global safety standards.
Specializes in automated blood and apheresis collection technologies, offering systems such as Trima Accel and Spectra Optia for blood component collection and processing. Automates and optimizes collection efficiency, enhances accuracy in component separation, reduces operator intervention, supports large-scale blood center operations, and ensures consistent product quality.
Manufactures high-quality blood collection tubes, needles, and accessories under the VACUETTE brand, widely used in clinical and diagnostic laboratories. Ensures reliable sample integrity, minimizes pre-analytical errors, provides compatibility with automated analyzers, enhances workflow efficiency, and supports high safety standards.
Supplies a range of blood collection and laboratory consumables, including safety-engineered needles, holders, and collection systems used in hospitals and diagnostic centers. Improves safety for healthcare professionals, reduces needlestick injuries, ensures consistent sample quality, simplifies handling, and enhances workflow efficiency in clinical settings.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The blood collection devices market caters to a broad spectrum of end users, including hospitals, ambulatory surgical centers, nursing homes, diagnostic and pathology laboratories, and blood banks. These end users rely on blood collection systems for diagnostic testing, transfusion, and therapeutic applications. The increasing prevalence of chronic and infectious diseases, coupled with the growing number of diagnostic procedures and surgical interventions, is fueling product adoption across these settings. Furthermore, the integration of safety-engineered devices, automation, and closed-system technologies is improving workflow efficiency, minimizing contamination risks, and enhancing patient and healthcare worker safety. Supportive healthcare policies, rising awareness of regular health checkups, and the expansion of clinical laboratory infrastructure continue to drive growth across all end-user segments.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Blood Collection Devices Market, By Product

The blood collection devices market is segmented into blood collection tubes, needles & syringes, blood bags, blood collection systems/monitors, and lancets. Among these, blood collection tubes dominate the market, driven by their widespread use in diagnostic testing, routine health check-ups, and blood banking procedures. These tubes enable multiple samples to be collected from a single patient for various tests, ensuring accuracy, convenience, and efficiency in clinical workflows. The growing prevalence of chronic and infectious diseases, coupled with increasing demand for reliable diagnostic results, further reinforces the strong demand for blood collection tubes. While other products such as needles, syringes, and blood bags play a vital role in overall blood collection processes, tubes remain the largest contributor to market revenue due to their consistent and recurring use across healthcare settings.

Blood Collection Devices Market, By Method

The blood collection devices market is divided into manual and automated blood collection methods. Manual blood collection continues to be widely used across hospitals, clinics, and blood banks due to its simplicity, cost-effectiveness, and adaptability to various clinical settings. It allows healthcare professionals to collect samples with minimal equipment requirements, making it suitable for both routine and emergency procedures. Manual methods remain essential in regions with limited access to advanced technologies, where they support large-scale diagnostic and therapeutic applications efficiently and reliably.

Blood Collection Devices Market, By Application

The blood collection devices market is categorized into diagnostic and therapeutic applications. Diagnostic applications account for a major share of usage, as blood testing remains essential for disease detection, health monitoring, and preventive screening. These applications support the identification of infections, chronic diseases, and other medical conditions through accurate and timely blood analysis. Therapeutic applications primarily involve transfusions and related procedures but represent a comparatively smaller portion of overall use. The growing emphasis on early diagnosis and regular health check-ups continues to drive the demand for blood collection devices in diagnostic settings.

Blood Collection Devices Market, By End User

The blood collection devices market is categorized by end user into hospitals, ambulatory surgical centers (ASCs), and nursing homes; diagnostic and pathology laboratories; blood banks; and other end users. Hospitals, ASCs, and nursing homes account for a substantial share of the market due to the high number of patient admissions, surgical procedures, and routine diagnostic tests conducted in these facilities. Diagnostic and pathology laboratories also represent a major end-user segment, as blood testing forms the foundation of disease detection, monitoring, and preventive healthcare. Blood banks rely on these devices for efficient collection, processing, and storage of blood and its components. The continuous expansion of healthcare infrastructure and increasing demand for accurate diagnostic testing are expected to further drive the adoption of blood collection devices across all end-user segments.

REGION

North America accounted for largest share of global blood collection devices market during forecast period

The blood collection devices market in North America is witnessing steady growth, supported by a robust healthcare infrastructure, significant healthcare spending, and increasing adoption of advanced diagnostic technologies. Rising cases of chronic and infectious diseases, along with a surge in surgical procedures and trauma cases, are driving the need for efficient and safe blood collection solutions across healthcare settings. Additionally, a strong presence of major industry players, favorable reimbursement policies, and ongoing technological innovations are further contributing to the market’s continued expansion in the region.

Blood Collection Devices Market: COMPANY EVALUATION MATRIX

Fresenius Kabi AG is a leading player in the global blood collection devices market, recognized for its wide range of high-quality blood bags, collection systems, and related consumables. The company’s strong expertise in transfusion and infusion technologies enables it to cater effectively to the needs of hospitals, blood banks, and healthcare institutions worldwide. With a well-established global presence and focus on product safety, reliability, and innovation, Fresenius Kabi continues to strengthen its position in the market. Strategic collaborations, continuous product enhancements, and a commitment to supporting blood donation and transfusion programs further reinforce the company’s leadership in the blood collection devices segment.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 8.61 Billion
Market Forecast in 2030 (Value) USD 13.02 Billion
Growth Rate CAGR of 7.4% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Million), Volume (Million)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By product (blood collection tubes, needles & syringes, blood bags, blood collection systems/monitors, lancets)
  • Method (manual blood collection, automated blood collection)
  • Application (diagnostic applications, therapeutic applications)
  • End user (hospitals, ASCs, and nursing homes; blood banks; diagnostic & pathology laboratories; other end users)
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

WHAT IS IN IT FOR YOU: Blood Collection Devices Market REPORT CONTENT GUIDE

RECENT DEVELOPMENTS

  • January 2025 : Terumo BCT signed a Memorandum of Understanding (MoU) on a strategic partnership with the Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection. This partnership will strengthen technical research and innovation, with emphasis on Terumo BCT's strategic product areas, including blood component collection. 
  • January 2025 : Fresenius Kabi received FDA clearance for Adaptive Nomogram, an alternate algorithm that will be available in the Aurora Xi Plasmapheresis System. The algorithm enables an average 11.5% increase in plasma collection per donation while maintaining safe and effective operation. 
  • December 2024 : BD, along with Babson Diagnostics, launched the BD MiniDraw Capillary Blood Collection System, which incorporates Babson's BetterWay technologies to enable test results from as few as six drops of capillary blood collected from a patient's finger.  
  • December 2023 : BD received 510(k) clearance from the US Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
28
2
RESEARCH METHODOLOGY
 
 
 
32
3
EXECUTIVE SUMMARY
 
 
 
44
4
PREMIUM INSIGHTS
 
 
 
47
5
MARKET OVERVIEW
Rising blood collection demands drive innovation amidst cost and skill challenges, unlocking emerging market potential.
 
 
 
51
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
RISING PREVALENCE OF INFECTIOUS DISEASES AND CHRONIC & LIFESTYLE DISEASES
 
 
 
 
5.2.1.2
INCREASING NUMBER OF HOSPITALS AND SURGICAL CENTERS
 
 
 
 
5.2.1.3
RISE IN ACCIDENTS AND TRAUMA CASES
 
 
 
 
5.2.1.4
EMERGENCE OF LIQUID BIOPSY TESTS
 
 
 
 
5.2.1.5
GROWING DEMAND FOR AND AWARENESS OF BLOOD DONATIONS AND BLOOD COMPONENTS
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
RISING COSTS OF AUTOMATED BLOOD COLLECTION DEVICES
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
INCREASING DEMAND FOR APHERESIS
 
 
 
 
5.2.3.2
LUCRATIVE OPPORTUNITIES IN EMERGING ECONOMIES
 
 
 
 
5.2.3.3
ADVANCEMENTS IN BLOOD COLLECTION
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
COMPLEX STORAGE AND SHIPPING
 
 
 
 
5.2.4.2
LACK OF SKILLED PROFESSIONALS
 
 
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
5.4
PRICING ANALYSIS
 
 
 
 
 
 
5.4.1
AVERAGE SELLING PRICE TREND, BY PRODUCT
 
 
 
 
5.4.2
AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY KEY PLAYER
 
 
 
 
5.4.3
AVERAGE SELLING PRICE TREND, BY REGION
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.6
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.7
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.8
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.9
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.9.1
KEY TECHNOLOGIES
 
 
 
 
 
5.9.1.1
CORE BLOOD COLLECTION DEVICES
 
 
 
5.9.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.9.2.1
SAMPLING AND COLLECTION KITS
 
 
5.10
PATENT ANALYSIS
 
 
 
 
 
5.11
TRADE ANALYSIS
 
 
 
 
 
 
5.11.1
IMPORT DATA
 
 
 
 
5.11.2
EXPORT DATA
 
 
 
5.12
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
5.13
CASE STUDY ANALYSIS
 
 
 
 
 
5.13.1
CASE STUDY 1: REDUCING HOSPITAL-ONSET BACTEREMIA USING PIVO NEEDLELESS BLOOD COLLECTION
 
 
 
 
5.13.2
CASE STUDY 2: ADOPTION OF PIVO NEEDLE-FREE BLOOD COLLECTION DEVICE AT VIRGINIA MASON MEDICAL CENTER
 
 
 
 
5.13.3
CASE STUDY 3: AUTONOMOUS BLOOD COLLECTION ENHANCES EFFICIENCY AND PATIENT EXPERIENCE AT ST. ANTONIUS HOSPITAL
 
 
 
5.14
REGULATORY ANALYSIS
 
 
 
 
 
5.14.1
REGULATORY LANDSCAPE
 
 
 
 
 
5.14.1.1
NORTH AMERICA
 
 
 
 
5.14.1.2
EUROPE
 
 
 
 
5.14.1.3
ASIA PACIFIC
 
 
 
 
5.14.1.4
LATIN AMERICA
 
 
 
 
5.14.1.5
MIDDLE EAST
 
 
 
 
5.14.1.6
AFRICA
 
 
 
5.14.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
5.15
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.15.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.15.2
BARGAINING POWER OF BUYERS
 
 
 
 
5.15.3
THREAT OF NEW ENTRANTS
 
 
 
 
5.15.4
THREAT OF SUBSTITUTES
 
 
 
 
5.15.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.16
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.16.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.16.2
BUYING CRITERIA
 
 
 
5.17
IMPACT OF GENERATIVE AI ON BLOOD COLLECTION DEVICES MARKET
 
 
 
 
 
5.17.1
INTRODUCTION
 
 
 
 
5.17.2
MARKET POTENTIAL FOR BLOOD COLLECTION DEVICES
 
 
 
 
5.17.3
AI USE CASES
 
 
 
 
5.17.4
KEY COMPANIES IMPLEMENTING AI
 
 
 
 
5.17.5
FUTURE OF GENERATIVE AI IN BLOOD COLLECTION DEVICES MARKET
 
 
 
5.18
IMPACT OF 2025 US TARIFFS ON BLOOD COLLECTION DEVICES MARKET
 
 
 
 
 
 
5.18.1
INTRODUCTION
 
 
 
 
5.18.2
KEY TARIFF RATES
 
 
 
 
5.18.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.18.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
5.18.4.1
NORTH AMERICA
 
 
 
 
5.18.4.2
EUROPE
 
 
 
 
5.18.4.3
ASIA PACIFIC
 
 
 
5.18.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
5.18.5.1
HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES
 
 
 
 
5.18.5.2
DIAGNOSTIC & PATHOLOGY LABS
 
 
 
 
5.18.5.3
BLOOD BANKS
 
6
BLOOD COLLECTION DEVICES MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 74 Data Tables
 
 
 
87
 
6.1
INTRODUCTION
 
 
 
 
6.2
BLOOD COLLECTION TUBES
 
 
 
 
 
6.2.1
BLOOD COLLECTION TUBES MARKET, BY TYPE
 
 
 
 
 
6.2.1.1
PLASMA/WHOLE-BLOOD TUBES
 
 
 
 
6.2.1.2
SERUM TUBES
 
 
 
6.2.2
BLOOD COLLECTION TUBES, BY SYSTEM TYPE
 
 
 
 
 
6.2.2.1
VACUUM TUBES
 
 
 
 
6.2.2.2
NON-VACUUM TUBES
 
 
6.3
NEEDLES & SYRINGES
 
 
 
 
 
6.3.1
RISING ADOPTION OF SAFETY BLOOD COLLECTION SETS TO BOLSTER GROWTH
 
 
 
6.4
BLOOD BAGS
 
 
 
 
 
6.4.1
INCREASING BLOOD DONATIONS WORLDWIDE TO AUGMENT GROWTH
 
 
 
6.5
BLOOD COLLECTION SYSTEMS/MONITORS
 
 
 
 
 
6.5.1
GROWING CONCERNS REGARDING BLOOD SAFETY AND BLOOD SHORTAGE TO PROPEL MARKET
 
 
 
6.6
LANCETS
 
 
 
 
 
6.6.1
HIGH CONVENIENCE AND MINIMAL PAIN TO CONTRIBUTE TO GROWTH
 
 
7
BLOOD COLLECTION DEVICES MARKET, BY METHOD
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 9 Data Tables
 
 
 
120
 
7.1
INTRODUCTION
 
 
 
 
7.2
MANUAL BLOOD COLLECTION
 
 
 
 
 
7.2.1
RISING INCLINATION TOWARD SELF-CARE AND INCREASING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE MARKET
 
 
 
7.3
AUTOMATED BLOOD COLLECTION
 
 
 
 
 
7.3.1
INCREASING DEMAND FOR SAFER COLLECTION PROCEDURES AND AVAILABILITY OF ADVANCED BLOOD-COLLECTING PRODUCTS TO AID GROWTH
 
 
8
BLOOD COLLECTION DEVICES MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
 
 
 
126
 
8.1
INTRODUCTION
 
 
 
 
8.2
DIAGNOSTIC APPLICATIONS
 
 
 
 
 
8.2.1
RISING INCIDENCE OF INFECTIOUS DISEASES TO SPUR GROWTH
 
 
 
8.3
THERAPEUTIC APPLICATIONS
 
 
 
 
 
8.3.1
RISING PREVALENCE OF HEMATOLOGICAL DISORDERS TO SUPPORT GROWTH
 
 
9
BLOOD COLLECTION DEVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 17 Data Tables
 
 
 
133
 
9.1
INTRODUCTION
 
 
 
 
9.2
HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES
 
 
 
 
 
9.2.1
INCREASING NUMBER OF SURGICAL PROCEDURES AND HOSPITALS TO FOSTER GROWTH
 
 
 
9.3
DIAGNOSTIC & PATHOLOGY LABORATORIES
 
 
 
 
 
9.3.1
RISING NUMBER OF TEST VOLUMES TO CONTRIBUTE TO GROWTH
 
 
 
9.4
BLOOD BANKS
 
 
 
 
 
9.4.1
INCREASING AWARENESS ABOUT BLOOD DONATION AND USE OF BLOOD FOR TREATING CLINICAL CONDITIONS TO BOOST MARKET
 
 
 
9.5
OTHER END USERS
 
 
 
10
BLOOD COLLECTION DEVICES MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 12 Countries | 151 Data Tables.
 
 
 
142
 
10.1
INTRODUCTION
 
 
 
 
10.2
NORTH AMERICA
 
 
 
 
 
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
10.2.2
US
 
 
 
 
 
10.2.2.1
HIGH HEALTHCARE EXPENDITURE AND INCREASING PREVALENCE OF CANCER TO EXPEDITE GROWTH
 
 
 
10.2.3
CANADA
 
 
 
 
 
10.2.3.1
GROWING VOLUME OF SURGICAL PROCEDURES TO SUPPORT GROWTH
 
 
10.3
EUROPE
 
 
 
 
 
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
10.3.2
GERMANY
 
 
 
 
 
10.3.2.1
INCREASING HEALTHCARE EXPENDITURE AND NEW BLOOD TESTS TO AID GROWTH
 
 
 
10.3.3
FRANCE
 
 
 
 
 
10.3.3.1
GROWING NUMBER OF NEW DIAGNOSTIC TESTS AND PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
 
 
 
10.3.4
UK
 
 
 
 
 
10.3.4.1
INCREASING PREVALENCE OF LIFESTYLE DISEASES AND HIV TO SPUR GROWTH
 
 
 
10.3.5
ITALY
 
 
 
 
 
10.3.5.1
RISING BLOOD DONATION TO CONTRIBUTE TO GROWTH
 
 
 
10.3.6
SPAIN
 
 
 
 
 
10.3.6.1
RISE IN ORGAN TRANSPLANTS TO AID GROWTH
 
 
 
10.3.7
REST OF EUROPE
 
 
 
10.4
ASIA PACIFIC
 
 
 
 
 
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
10.4.2
JAPAN
 
 
 
 
 
10.4.2.1
RAPID INCREASE IN AGING POPULATION TO ACCELERATE GROWTH
 
 
 
10.4.3
CHINA
 
 
 
 
 
10.4.3.1
GROWING DEMAND FOR BLOOD COMPONENTS TO FACILITATE GROWTH
 
 
 
10.4.4
INDIA
 
 
 
 
 
10.4.4.1
RISE IN GOVERNMENT INITIATIVES FOR HEALTHCARE INFRASTRUCTURE TO ACCELERATE GROWTH
 
 
 
10.4.5
AUSTRALIA
 
 
 
 
 
10.4.5.1
GROWING EMPHASIS ON IMPROVING ACCESS TO DIAGNOSTIC AND PREVENTIVE HEALTHCARE TO FUEL MARKET
 
 
 
10.4.6
REST OF ASIA PACIFIC
 
 
 
10.5
LATIN AMERICA
 
 
 
 
 
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
10.6
MIDDLE EAST & AFRICA
 
 
 
 
 
10.6.1
PREVALENCE OF INFECTIOUS DISEASES AND GROWING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
 
 
 
 
10.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
11
COMPETITIVE LANDSCAPE
Discover emerging leaders and strategies reshaping market dominance through detailed competitive benchmarking insights.
 
 
 
207
 
11.1
OVERVIEW
 
 
 
 
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
11.2.1
OVERVIEW OF KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS
 
 
 
11.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
11.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
11.5
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
11.6
BRAND/PRODUCT COMPARISON
 
 
 
 
 
11.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
11.7.1
STARS
 
 
 
 
11.7.2
EMERGING LEADERS
 
 
 
 
11.7.3
PERVASIVE PLAYERS
 
 
 
 
11.7.4
PARTICIPANTS
 
 
 
 
11.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
11.7.5.1
COMPANY FOOTPRINT
 
 
 
 
11.7.5.2
REGION FOOTPRINT
 
 
 
 
11.7.5.3
PRODUCT FOOTPRINT
 
 
 
 
11.7.5.4
APPLICATION FOOTPRINT
 
 
 
 
11.7.5.5
METHOD FOOTPRINT
 
 
11.8
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
 
 
11.8.1
PROGRESSIVE COMPANIES
 
 
 
 
11.8.2
RESPONSIVE COMPANIES
 
 
 
 
11.8.3
DYNAMIC COMPANIES
 
 
 
 
11.8.4
STARTING BLOCKS
 
 
 
 
11.8.5
COMPETITIVE BENCHMARKING
 
 
 
 
 
11.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
11.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
11.9
COMPETITIVE SCENARIO
 
 
 
 
 
11.9.1
PRODUCT LAUNCHES AND APPROVALS
 
 
 
 
11.9.2
DEALS
 
 
 
 
11.9.3
EXPANSIONS
 
 
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
221
 
12.1
KEY PLAYERS
 
 
 
 
 
12.1.1
BECTON, DICKINSON AND COMPANY (BD)
 
 
 
 
 
12.1.1.1
BUSINESS OVERVIEW
 
 
 
 
12.1.1.2
PRODUCTS OFFERED
 
 
 
 
12.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.1.4
MNM VIEW
 
 
 
12.1.2
TERUMO BCT, INC.
 
 
 
 
12.1.3
FRESENIUS KABI AG
 
 
 
 
12.1.4
GRIFOLS, S.A.
 
 
 
 
12.1.5
NIPRO CORPORATION
 
 
 
 
12.1.6
SARSTEDT AG & CO. KG
 
 
 
 
12.1.7
MACOPHARMA
 
 
 
 
12.1.8
HAEMONETICS CORPORATION
 
 
 
 
12.1.9
ICU MEDICAL, INC.
 
 
 
 
12.1.10
CARDINAL HEALTH
 
 
 
 
12.1.11
RETRACTABLE TECHNOLOGIES, INC.
 
 
 
 
12.1.12
GREINER HOLDING AG
 
 
 
12.2
OTHER PLAYERS
 
 
 
 
 
12.2.1
LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.
 
 
 
 
12.2.2
FL MEDICAL S.R.L.
 
 
 
 
12.2.3
AB MEDICAL CO., LTD.
 
 
 
 
12.2.4
APTACA SPA
 
 
 
 
12.2.5
JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD.
 
 
 
 
12.2.6
DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S
 
 
 
 
12.2.7
AJOSHA BIO TEKNIK PVT. LTD.
 
 
 
 
12.2.8
PREQ SYSTEMS
 
 
 
 
12.2.9
CML BIOTECH LTD
 
 
 
 
12.2.10
LMB TECHNOLOGIE GMBH
 
 
 
 
12.2.11
MITRA INDUSTRIES PRIVATE LIMITED
 
 
 
 
12.2.12
NEOMEDIC LIMITED
 
 
 
 
12.2.13
MHC MEDICAL PRODUCTS, LLC
 
 
13
APPENDIX
 
 
 
262
 
13.1
DISCUSSION GUIDE
 
 
 
 
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
13.3
CUSTOMIZATION OPTIONS
 
 
 
 
13.4
RELATED REPORTS
 
 
 
 
13.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
BLOOD COLLECTION DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
 
 
 
 
TABLE 2
BLOOD COLLECTION DEVICES MARKET: RISK ANALYSIS
 
 
 
 
TABLE 3
AVERAGE SELLING PRICING TREND OF BLOOD COLLECTION TUBES AND LANCETS, 2023–2025 (USD)
 
 
 
 
TABLE 4
AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY KEY PLAYER, 2023–2025 (USD)
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY REGION, 2023–2025 (USD)
 
 
 
 
TABLE 6
BLOOD COLLECTION DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
TABLE 7
BLOOD COLLECTION DEVICES MARKET: LIST OF MAJOR PATENTS, 2023–2025
 
 
 
 
TABLE 8
IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD MILLION)
 
 
 
 
TABLE 9
EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
 
 
 
 
TABLE 10
BLOOD COLLECTION DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
TABLE 11
EUROPE: CLASSIFICATION OF DEVICES
 
 
 
 
TABLE 12
JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
 
 
 
 
TABLE 13
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 14
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 15
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 16
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 17
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 18
BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
 
 
 
 
TABLE 20
KEY BUYING CRITERIA, BY END USER
 
 
 
 
TABLE 21
RECIPROCAL TARIFF RATES ADJUSTED BY US
 
 
 
 
TABLE 22
BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 23
BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 24
BLOOD COLLECTION TUBES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 25
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 26
EUROPE: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 27
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 28
PLASMA/WHOLE-BLOOD TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 29
BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 30
BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 31
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 32
EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
EDTA TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 35
BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
EUROPE: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
HEPARIN TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 40
BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
EUROPE: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
COAGULATION TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 45
BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
EUROPE: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
GLUCOSE TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 50
BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 52
EUROPE: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
ESR TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 55
BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 56
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
EUROPE: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 58
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
SERUM TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 60
BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
EUROPE: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 64
BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
VACUUM TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 66
BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 68
EUROPE: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
NON-VACUUM TUBES AVAILABLE IN MARKET
 
 
 
 
TABLE 71
BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 72
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
EUROPE: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 75
NEEDLES & SYRINGES AVAILABLE IN MARKET
 
 
 
 
TABLE 76
BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 78
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
BLOOD BAGS AVAILABLE IN MARKET
 
 
 
 
TABLE 81
BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 82
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 83
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 84
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
BLOOD COLLECTION SYSTEMS/MONITORS AVAILABLE IN MARKET
 
 
 
 
TABLE 86
BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 88
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 89
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 90
LANCETS AVAILABLE IN MARKET
 
 
 
 
TABLE 91
BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 92
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
GLOBAL NUMBER OF LANCETS MANUFACTURED, 2023–2030 (UNITS)
 
 
 
 
TABLE 96
BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 100
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 104
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
REGIONAL HIV DATA, 2024
 
 
 
 
TABLE 107
BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 130
EUROPE: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
BLOOD COLLECTION DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
NORTH AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 134
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 141
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 143
US: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
US: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
US: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
US: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
SURGICAL PROCEDURES PERFORMED IN CANADA, 2024
 
 
 
 
TABLE 150
CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 151
CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
CANADA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 153
CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 155
CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 156
CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 157
EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 159
EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 161
EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 163
EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
SURGICAL PROCEDURES PERFORMED IN GERMANY, 2024
 
 
 
 
TABLE 166
GERMANY: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 167
GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
GERMANY: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 170
GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 172
GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 174
SURGICAL PROCEDURES PERFORMED IN FRANCE, 2024
 
 
 
 
TABLE 175
FRANCE: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 176
FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 177
FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 178
FRANCE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 179
FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 180
FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 181
FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 182
FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 183
SURGICAL PROCEDURES PERFORMED IN UK, 2024
 
 
 
 
TABLE 184
UK: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 185
UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 186
UK: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 187
UK: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 188
UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 189
UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 190
UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 191
UK: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 192
SURGICAL PROCEDURES PERFORMED IN ITALY, 2024
 
 
 
 
TABLE 193
ITALY: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 194
ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 195
ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 196
ITALY: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 197
ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 198
ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 199
ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 200
ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 201
SURGICAL PROCEDURES PERFORMED IN SPAIN, 2024
 
 
 
 
TABLE 202
SPAIN: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 203
SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 204
SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 205
SPAIN: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 206
SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 207
SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 208
SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 209
SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 210
REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2020 VS. 2024 (% OF GDP)
 
 
 
 
TABLE 211
PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050
 
 
 
 
TABLE 212
SURGICAL PROCEDURES PERFORMED IN SWITZERLAND, 2024
 
 
 
 
TABLE 213
REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 214
REST OF EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 215
REST OF EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 216
REST OF EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 217
REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 218
REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 219
REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 220
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 221
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 222
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 223
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 224
ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 225
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 226
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 227
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 228
JAPAN: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 229
JAPAN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 230
JAPAN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 231
JAPAN: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 232
JAPAN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 233
JAPAN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 234
JAPAN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 235
JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 236
CHINA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 237
CHINA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 238
CHINA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 239
CHINA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 240
CHINA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 241
CHINA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 242
CHINA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 243
CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 244
INDIA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 245
INDIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 246
INDIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 247
INDIA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 248
INDIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 249
INDIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 250
INDIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 251
INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 252
AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 253
AUSTRALIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 254
AUSTRALIA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 255
AUSTRALIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 256
AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 257
AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 258
AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 259
SURGICAL PROCEDURES IN SOUTH KOREA, 2024
 
 
 
 
TABLE 260
REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 261
REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 262
REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 263
REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 264
REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 265
REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 266
REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 267
LATIN AMERICA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 268
LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 269
LATIN AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 270
LATIN AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 271
LATIN AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 272
LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 273
LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 274
LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 275
MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 276
MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 277
MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 278
MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 279
MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 280
MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 281
MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 282
MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 283
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD COLLECTION DEVICES MARKET, JANUARY 2022−JUNE 2025
 
 
 
 
TABLE 284
BLOOD COLLECTION DEVICES MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 285
BLOOD COLLECTION DEVICES MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 286
BLOOD COLLECTION DEVICES MARKET: PRODUCT FOOTPRINT
 
 
 
 
TABLE 287
BLOOD COLLECTION DEVICES MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 288
BLOOD COLLECTION DEVICES MARKET: METHOD FOOTPRINT
 
 
 
 
TABLE 289
BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 290
BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND METHOD
 
 
 
 
TABLE 291
BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION
 
 
 
 
TABLE 292
BLOOD COLLECTION DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 293
BLOOD COLLECTION DEVICES MARKET: DEALS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 294
BLOOD COLLECTION DEVICES MARKET: EXPANSIONS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 295
BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
 
 
 
 
TABLE 296
BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
 
 
 
 
TABLE 297
BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 298
BECTON, DICKINSON AND COMPANY (BD): EXPANSIONS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 299
BECTON, DICKINSON AND COMPANY (BD): DEALS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 300
TERUMO BCT, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 301
EXCHANGE RATES USED FOR CONVERSION OF YEN TO USD, 2022–2024
 
 
 
 
TABLE 302
TERUMO BCT, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 303
TERUMO BCT, INC.: DEALS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 304
FRESENIUS KABI AG: COMPANY OVERVIEW
 
 
 
 
TABLE 305
EXCHANGE RATES USED FOR CONVERSION OF EURO TO USD, 2022–2024
 
 
 
 
TABLE 306
FRESENIUS KABI AG: PRODUCTS OFFERED
 
 
 
 
TABLE 307
FRESENIUS KABI AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 308
GRIFOLS, S.A.: COMPANY OVERVIEW
 
 
 
 
TABLE 309
GRIFOLS, S.A.: PRODUCTS OFFERED
 
 
 
 
TABLE 310
NIPRO CORPORATION: BUSINESS OVERVIEW
 
 
 
 
TABLE 311
NIPRO CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 312
SARSTEDT AG & CO. KG: COMPANY OVERVIEW
 
 
 
 
TABLE 313
SARSTEDT AG & CO. KG: PRODUCTS OFFERED
 
 
 
 
TABLE 314
MACOPHARMA: COMPANY OVERVIEW
 
 
 
 
TABLE 315
MACOPHARMA: PRODUCTS OFFERED
 
 
 
 
TABLE 316
HAEMONETICS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 317
HAEMONETICS CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 318
HAEMONETICS CORPORATION: DEALS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 319
HAEMONETICS CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 320
HAEMONETICS CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025
 
 
 
 
TABLE 321
ICU MEDICAL, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 322
ICU MEDICAL, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 323
CARDINAL HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 324
CARDINAL HEALTH: PRODUCTS OFFERED
 
 
 
 
TABLE 325
RETRACTABLE TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 326
RETRACTABLE TECHNOLOGIES, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 327
GREINER HOLDING AG: COMPANY OVERVIEW
 
 
 
 
TABLE 328
GREINER HOLDING AG: PRODUCTS OFFERED
 
 
 
 
TABLE 329
LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 330
FL MEDICAL S.R.L.: COMPANY OVERVIEW
 
 
 
 
TABLE 331
AB MEDICAL CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 332
APTACA SPA: COMPANY OVERVIEW
 
 
 
 
TABLE 333
JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 334
DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S: COMPANY OVERVIEW
 
 
 
 
TABLE 335
AJOSHA BIO TEKNIK PVT. LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 336
PREQ SYSTEMS: COMPANY OVERVIEW
 
 
 
 
TABLE 337
CML BIOTECH LTD: COMPANY OVERVIEW
 
 
 
 
TABLE 338
LMB TECHNOLOGIE GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 339
MITRA INDUSTRIES PRIVATE LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 340
NEOMEDIC LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 341
MHC MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
BLOOD COLLECTION DEVICES MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
FIGURE 2
RESEARCH DESIGN
 
 
 
 
FIGURE 3
BLOOD COLLECTION DEVICES MARKET: KEY PRIMARY SOURCES
 
 
 
 
FIGURE 4
BLOOD COLLECTION DEVICES MARKET: KEY INSIGHTS FROM PRIMARIES
 
 
 
 
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
 
 
 
 
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 7
BLOOD COLLECTION DEVICES MARKET: COMPANY REVENUE ESTIMATION APPROACH
 
 
 
 
FIGURE 8
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 9
TOP-DOWN APPROACH
 
 
 
 
FIGURE 10
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 11
BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 12
BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 13
BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 14
BLOOD COLLECTION DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
BLOOD COLLECTION DEVICES MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 16
INCREASING DISEASE INCIDENCE AND DEMAND FOR BLOOD COMPONENTS TO DRIVE MARKET
 
 
 
 
FIGURE 17
BLOOD COLLECTION TUBES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 18
MANUAL BLOOD COLLECTION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 19
DIAGNOSTIC APPLICATIONS SEGMENT TO SHOWCASE LARGEST MARKET SHARE DURING FORECAST PERIOD
 
 
 
 
FIGURE 20
HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030
 
 
 
 
FIGURE 21
NORTH AMERICAN MARKET TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
 
 
 
 
FIGURE 22
BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 23
INCREASING INCIDENCE OF DIABETES, 2021 VS. 2045 (MILLION)
 
 
 
 
FIGURE 24
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
FIGURE 25
VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
 
 
 
 
FIGURE 26
SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY FOR PROMINENT COMPANIES
 
 
 
 
FIGURE 27
BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 28
BLOOD COLLECTION DEVICES MARKET: INVESTMENT AND FUNDING SCENARIO, 2020−2023
 
 
 
 
FIGURE 29
BLOOD COLLECTION DEVICES MARKET: PATENT ANALYSIS, JANUARY 2014–DECEMBER 2024
 
 
 
 
FIGURE 30
BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 31
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
 
 
 
 
FIGURE 32
KEY BUYING CRITERIA, BY END USER
 
 
 
 
FIGURE 33
AI USE CASES
 
 
 
 
FIGURE 34
NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET SNAPSHOT
 
 
 
 
FIGURE 35
ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET SNAPSHOT
 
 
 
 
FIGURE 36
REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD COLLECTION DEVICES MARKET, 2022–2024
 
 
 
 
FIGURE 37
BLOOD COLLECTION DEVICES MARKET SHARE ANALYSIS, 2024
 
 
 
 
FIGURE 38
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 39
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 40
BLOOD COLLECTION DEVICES MARKET: BRAND/PRODUCT COMPARISON
 
 
 
 
FIGURE 41
BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 42
BLOOD COLLECTION DEVICES MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 43
BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 44
BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
 
 
 
 
FIGURE 45
TERUMO BCT, INC.: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 46
FRESENIUS KABI AG: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 47
GRIFOLS, S.A.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 48
NIPRO CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 49
HAEMONETICS CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 50
ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 51
CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 52
RETRACTABLE TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 53
GREINER HOLDING AG: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

The following is a breakdown of the primary respondents:

Blood Collection Devices Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Blood Collection Devices Market

Data Triangulation

The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.

Stakeholders

  • Healthcare Service Providers (Hospitals and Pathology Centers)
  • Blood Collection Product Manufacturers
  • Blood Banks
  • Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

Report Objectives

  • To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
  • To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
  • To profile the key players in the market and comprehensively analyze their market positions and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Blood Collection Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Blood Collection Devices Market

Samuel

Oct, 2022

Who is the targeted audience for this Study?.

Louie

Oct, 2022

What will be the market value for Blood Collection Devices Market in 2028?.

Mason

Oct, 2022

Which factors are responsible for restraining the growth of Blood Collection Devices Market?.

DMCA.com Protection Status